Surgery is the treatment of choice
RANKL inhibitors (Denosumab) for unresectable metastatic disease
Can recur locally after curettage
Giant cell tumor
Multiple myeloma
Ganglion cyst
Chondrosarcoma
Eumycetoma
Paget disease
Neuroblastoma 
Osteosarcoma